novo nordisk glp 1 oral launched an version of its GLP-1 injectable to US markets on Jan 5. Link in comments Novo Nordisk's Oral Semaglutide Reduces

Resistance training preserves up to 97% lean mass during weight loss

The exact mechanisms underlying tirzepatide-induced weight loss remain to be clarified

Mounjaro & Ozempic Drug Interactions Taking Ozempic or Mounjaro may interact with certain medications, leading to an increased risk of hypoglycemia and affecting the effectiveness of oral medications due to changes in stomach emptying

Conclusions - The prevalence of CKD is high in DM2 and DKD is associated with increased cardiovascular risk, mortality and progression to end-stage CKD, requiring early and intensive treatment to minimize these complications

The development of double agonists and even multiple agonists has also improved the limitations of GLP-1R in the treatment of metabolic diseases and provided better treatment options